These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Relevance of Assembly-Activating Protein for Adeno-associated Virus Vector Production and Capsid Protein Stability in Mammalian and Insect Cells. Grosse S; Penaud-Budloo M; Herrmann AK; Börner K; Fakhiri J; Laketa V; Krämer C; Wiedtke E; Gunkel M; Ménard L; Ayuso E; Grimm D J Virol; 2017 Oct; 91(20):. PubMed ID: 28768875 [TBL] [Abstract][Full Text] [Related]
5. Light-Activated Nuclear Translocation of Adeno-Associated Virus Nanoparticles Using Phytochrome B for Enhanced, Tunable, and Spatially Programmable Gene Delivery. Gomez EJ; Gerhardt K; Judd J; Tabor JJ; Suh J ACS Nano; 2016 Jan; 10(1):225-37. PubMed ID: 26618393 [TBL] [Abstract][Full Text] [Related]
6. Mutants at the 2-Fold Interface of Adeno-associated Virus Type 2 (AAV2) Structural Proteins Suggest a Role in Viral Transcription for AAV Capsids. Aydemir F; Salganik M; Resztak J; Singh J; Bennett A; Agbandje-McKenna M; Muzyczka N J Virol; 2016 Aug; 90(16):7196-7204. PubMed ID: 27252527 [TBL] [Abstract][Full Text] [Related]
8. Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus. Warrington KH; Gorbatyuk OS; Harrison JK; Opie SR; Zolotukhin S; Muzyczka N J Virol; 2004 Jun; 78(12):6595-609. PubMed ID: 15163751 [TBL] [Abstract][Full Text] [Related]
9. Mapping an Adeno-associated Virus 9-Specific Neutralizing Epitope To Develop Next-Generation Gene Delivery Vectors. Giles AR; Govindasamy L; Somanathan S; Wilson JM J Virol; 2018 Oct; 92(20):. PubMed ID: 30089698 [TBL] [Abstract][Full Text] [Related]
10. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. Kern A; Schmidt K; Leder C; Müller OJ; Wobus CE; Bettinger K; Von der Lieth CW; King JA; Kleinschmidt JA J Virol; 2003 Oct; 77(20):11072-81. PubMed ID: 14512555 [TBL] [Abstract][Full Text] [Related]
11. Conjugation of paclitaxel on adeno-associated virus (AAV) nanoparticles for co-delivery of genes and drugs. Wei F; McConnell KI; Yu TK; Suh J Eur J Pharm Sci; 2012 Jun; 46(3):167-72. PubMed ID: 22406091 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site. Huang LY; Patel A; Ng R; Miller EB; Halder S; McKenna R; Asokan A; Agbandje-McKenna M J Virol; 2016 Jun; 90(11):5219-5230. PubMed ID: 26962225 [TBL] [Abstract][Full Text] [Related]
13. Adeno-associated viral vectors and their redirection to cell-type specific receptors. Michelfelder S; Trepel M Adv Genet; 2009; 67():29-60. PubMed ID: 19914449 [TBL] [Abstract][Full Text] [Related]
15. High capsid-genome correlation facilitates creation of AAV libraries for directed evolution. Nonnenmacher M; van Bakel H; Hajjar RJ; Weber T Mol Ther; 2015 Apr; 23(4):675-82. PubMed ID: 25586687 [TBL] [Abstract][Full Text] [Related]
16. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Shi W; Arnold GS; Bartlett JS Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765 [TBL] [Abstract][Full Text] [Related]
17. Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or production. Zhang HG; Xie J; Dmitriev I; Kashentseva E; Curiel DT; Hsu HC; Mountz JD J Virol; 2002 Dec; 76(23):12023-31. PubMed ID: 12414944 [TBL] [Abstract][Full Text] [Related]
18. Site-specific modification of adeno-associated viruses via a genetically engineered aldehyde tag. Liu Y; Fang Y; Zhou Y; Zandi E; Lee CL; Joo KI; Wang P Small; 2013 Feb; 9(3):421-9. PubMed ID: 23038676 [TBL] [Abstract][Full Text] [Related]
19. Chimeric virus-like particle formation of adeno-associated virus. Hoque M; Shimizu N; Ishizu Ki; Yajima H; Arisaka F; Suzuki K; Watanabe H; Handa H Biochem Biophys Res Commun; 1999 Dec; 266(2):371-6. PubMed ID: 10600510 [TBL] [Abstract][Full Text] [Related]
20. A directed evolution approach to select for novel Adeno-associated virus capsids on an HIV-1 producer T cell line. Wooley DP; Sharma P; Weinstein JR; Kotha Lakshmi Narayan P; Schaffer DV; Excoffon KJDA J Virol Methods; 2017 Dec; 250():47-54. PubMed ID: 28918073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]